News & Highlights
Increasing enrollment in Alzheimer’s disease, other clinical trials
January 31, 2013
The goals of the new National Plan to Address Alzheimer’s Disease include increasing recruitment into clinical trials for Alzheimer’s and...
NIH-supported Alzheimer’s studies to focus on innovative treatments
January 14, 2013
With new research funding from the National Institutes of Health, the nation’s premier Alzheimer’s disease study network will undertake...
Latest NIH Alzheimer’s research progress report available
January 14, 2013
A new online report from the National Institutes of Health (NIH) highlights recent progress in NIH-supported Alzheimer’s disease research....
Recruiting patients for Alzheimer’s clinical trials
December 15, 2012
By Neil S. Buckholtz, PhD, Director, Division of Neuroscience, NIA Geriatricians are on the front lines of treating people with Alzheimer’s...
NIA researchers find protein PGC-1alpha may play important role in brain health
December 12, 2012
The human brain is made up of tens of billions of neurons, brain cells that act as information messengers, transmitting and receiving chemical and...
NIH-supported international teams identify rare Alzheimer’s disease risk gene variant
November 15, 2012
Two international teams of researchers, with NIH scientists and support, have separately identified a rare variation in the TREM2 gene as a moderate...
New database aims to capture international Alzheimer’s disease research efforts
October 10, 2012
NIH, Alzheimer’s Association invite research funders to participate A new, publicly available database is seeking to capture the full...
Dr. Neil Buckholtz named head of Division of Neuroscience
October 2, 2012
The National Institute on Aging is pleased to announce that Neil Buckholtz, Ph.D., has been appointed as the new Director of the Division of...
Risk gene for Alzheimer’s disease associated with lower brain amyloid
October 1, 2012
Researchers investigating a known gene risk factor for Alzheimer’s disease discovered it is associated with lower levels of beta amyloid—...
Investigators create “brain map” of key epigenetic processes
August 14, 2012
Epigenetics, the study of how the environment modifies the way the human gene is expressed, is an emerging frontier in science. Diet and exposure to...
New, improved Alzheimer's clinical trials finder launched
August 7, 2012
An updated service from the Alzheimer’s Disease Education and Referral (ADEAR) is making it easier than ever for people to find clinical...
New online tip sheets for Alzheimer’s caregivers
August 7, 2012
Every day can bring a new change or challenge for caregivers of people with Alzheimer’s disease. Now, practical information and advice is at...
Register now for "Unveiling the NIH Toolbox" meeting, Sept 10-11
July 25, 2012
Registration is now open for “Unveiling the NIH Toolbox,” a free scientific conference to be held September 10-11 in Bethesda, Maryland. The meeting...
Experimental Alzheimer’s drug shows promise in small, early-phase clinical studies
July 12, 2012
Posiphen, a drug candidate designed and developed by researchers in the NIA’s Intramural Research Program, has been shown in three small, early...
Exendin-4: From lizard to laboratory... and beyond
July 11, 2012
Throughout history, the natural world has served as a rich resource for compounds to treat human disease. For example, clay tablets from Mesopotamia...
Clinical trials now recruiting
July 11, 2012
Numerous clinical trials and studies are currently recruiting participants with and without Alzheimer's disease, mild cognitive impairment or...
Researchers, advocates gather at Summit to accelerate Alzheimer’s research
July 1, 2012
Dr. Francis Collins "We are at an exceptional moment scientifically for Alzheimer's,...
CADRO: Common Alzheimer's Disease Research Ontology
June 29, 2012
The creation of the first iteration of the Common Alzheimer Disease Research Ontology (CADRO) is a collaborative effort between the National...
NIH steps up efforts on clinical research awareness
June 15, 2012
A new section of the NIH website—NIH Clinical Research Trials and You—is designed to help the public and the practicing medical community...
Cancer drug bexarotene reverses Alzheimer’s deficits in mice
June 1, 2012
In two recent studies, NIA-supported investigators identified a surprising new candidate drug treatment for Alzheimer’s disease (AD) and...